Stock Comparison
ABBV vs BIIB
AbbVie Inc and Biogen Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$439.97B
$31.25B
P/E (TTM)
70.3
37.5
Forward P/E
17.7
17.3
Price/Sales
6.8
3.1
Price/Book
51.1
1.7
EV/EBITDA
25.8
17.8
Dividend Yield
2.03%
—
Profitability
Net Margin
9.82%
8.39%
Operating Margin
29.77%
12.79%
Return on Equity
62.30%
4.58%
Return on Assets
10.50%
5.21%
Growth (YoY)
Revenue Growth
10.20%
3.40%
Earnings Growth
290.40%
-84.80%
Price & Risk
Beta
0.3
0.2
52-Week High
$263.65
$216.63
52-Week Low
$197.38
$132.22
Analyst Target
$274.36
$235.32
Compare ABBV and BIIB your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.